Enhancing the promise of drug repositioning through genetics

Frontiers in Pharmacology

Volumn 8, Issue DEC, 2017, Pages

  Pritchard, Jayne Louise E ^a   O'Mara, Tracy A ^a   Glubb, Dylan M ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Drug repositioning; EQTL; Functional genomics; Genetics; GWAS; Therapeutics

Indexed keywords

PROPROTEIN CONVERTASE 9;

CHROMATIN; DRUG IDENTIFICATION; DRUG REPOSITIONING; DRUG TARGETING; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; GENETIC CODE; GENETIC TRAIT; GENETIC VARIABILITY; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMAN; PCSK9 GENE; QUANTITATIVE TRAIT LOCUS; SHORT SURVEY;

EID: 85037745481     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2017.00896     Document Type: Short Survey

References (74)

1. Amberger, J. S., Bocchini, C. A., Schiettecatte, F., Scott, A. F., and Hamosh, A. (2015). OMIM.org: online Mendelian Inheritance in Man (OMIM(R)), an online catalog of human genes and genetic disorders. Nucleic Acids Res. 43, D789-D798. doi: 10.1093/nar/gku1205
2. Ardlie, K. G., Deluca, D. S., Segrè, A. V., Sullivan, T. J., Young, T. R., Gelfand, E. T., et al. (2015). The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648-660. doi: 10.1126/science.1262110
3. Barrett, T., Wilhite, S. E., Ledoux, P., Evangelista, C., Kim, I. F., Tomashevsky, M., et al. (2013). NCBI GEO: archive for functional genomics data sets-update. Nucleic Acids Res. 41, D991-D995. doi: 10.1093/nar/gks1193
4. Battle, A., Mostafavi, S., Zhu, X., Potash, J. B., Weissman, M. M., McCormick, C., et al. (2014). Characterizing the genetic basis of transcriptome diversity through RNA-sequencing of 922 individuals. Genome Res. 24, 14-24. doi: 10.1101/gr.155192.113
5. Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., et al. (2007). Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat. Genet. 39, 1329-1337. doi: 10.1038/ng.2007.17
6. Caicedo, J. C., Singh, S., and Carpenter, A. E. (2016). Applications in image-based profiling of perturbations. Curr. Opin. Biotechnol. 39, 134-142. doi: 10.1016/j.copbio.2016.04.003
7. Chadwick, L. H. (2012). The NIH roadmap epigenomics program data resource. Epigenomics 4, 317-324. doi: 10.2217/epi.12.18
8. Cheng, T. H., Thompson, D. J., O'Mara, T. A., Painter, J. N., Glubb, D. M., Flach, S., et al. (2016). Five endometrial cancer risk loci identified through genome-wide association analysis. Nat. Genet. 48, 667-674. doi: 10.1038/ng.3562
9. Corradin, O., Saiakhova, A., Akhtar-Zaidi, B., Myeroff, L., Willis, J., Cowper-Sal-Lari, R., et al. (2014). Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits. Genome Res. 24, 1-13. doi: 10.1101/gr.164079.113
10. Davis, A. P., Grondin, C. J., Johnson, R. J., Sciaky, D., King, B. L., McMorran, R., et al. (2017). The comparative toxicogenomics database: update 2017. Nucleic Acids Res. 45, D972-D978. doi: 10.1093/nar/gkw838
11. Denny, J. C., Bastarache, L., Ritchie, M. D., Carroll, R. J., Zink, R., Mosley, J. D., et al. (2013). Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat. Biotechnol. 31, 1102-1111. doi: 10.1038/nbt.2749
12. Denny, J. C., Ritchie, M. D., Basford, M. A., Pulley, J. M., Bastarache, L., Brown-Gentry, K., et al. (2010). PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations. Bioinformatics 26, 1205-1210. doi: 10.1093/bioinformatics/btq126
13. Dina, C., Meyre, D., Gallina, S., Durand, E., Korner, A., Jacobson, P., et al. (2007). Variation in FTO contributes to childhood obesity and severe adult obesity. Nat. Genet. 39, 724-726. doi: 10.1038/ng2048
14. Dunning, A. M., Michailidou, K., Kuchenbaecker, K. B., Thompson, D., French, J. D., Beesley, J., et al. (2016). Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. Nat. Genet. 48, 374-386. doi: 10.1038/ng.3521
15. Edwards, S. L., Beesley, J., French, J. D., and Dunning, A. M. (2013). Beyond GWASs: illuminating the dark road from association to function. Am. J. Hum. Genet. 93, 779-797. doi: 10.1016/j.ajhg.2013.10.012
16. Encode Project Consortium (2012). An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74. doi: 10.1038/nature11247
17. Frayling, T. M., Timpson, N. J., Weedon, M. N., Zeggini, E., Freathy, R. M., Lindgren, C. M., et al. (2007). A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316, 889-894. doi: 10.1126/science.1141634
18. Gaffen, S. L., Jain, R., Garg, A. V., and Cua, D. J. (2014). The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat. Rev. Immunol. 14, 585-600. doi: 10.1038/nri3707
19. Gamazon, E. R., Wheeler, H. E., Shah, K. P., Mozaffari, S. V., Aquino-Michaels, K., Carroll, R. J., et al. (2015). A gene-based association method for mapping traits using reference transcriptome data. Nat. Genet. 47, 1091-1098. doi: 10.1038/ng.3367
20. Gao, T., He, B., Liu, S., Zhu, H., Tan, K., and Qian, J. (2016). EnhancerAtlas: a resource for enhancer annotation and analysis in 105 human cell/tissue types. Bioinformatics 32, 3543-3551. doi: 10.1093/bioinformatics/btw495
21. Gaulton, A., Hersey, A., Nowotka, M., Bento, A. P., Chambers, J., Mendez, D., et al. (2017). The ChEMBL database in 2017. Nucleic Acids Res. 45, D945-D954. doi: 10.1093/nar/gkw1074
22. Gilson, M. K., Liu, T., Baitaluk, M., Nicola, G., Hwang, L., and Chong, J. (2016). BindingDB in 2015: a public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Res. 44, D1045-D1053. doi: 10.1093/nar/gkv1072
23. Glubb, D. M., Johnatty, S. E., Quinn, M. C. J., O'Mara, T. A., Tyrer, J. P., Gao, B., et al. (2017). Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci. Oncotarget 8, 64670-64684. doi: 10.18632/oncotarget.18501
24. Glubb, D. M., Maranian, M. J., Michailidou, K., Pooley, K. A., Meyer, K. B., Kar, S., et al. (2015). Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. Am. J. Hum. Genet. 96, 5-20. doi: 10.1016/j.ajhg.2014.11.009
25. Greene, C. S., Krishnan, A., Wong, A. K., Ricciotti, E., Zelaya, R. A., Himmelstein, D. S., et al. (2015). Understanding multicellular function and disease with human tissue-specific networks. Nat. Genet. 47, 569-576. doi: 10.1038/ng.3259
26. Gusev, A., Ko, A., Shi, H., Bhatia, G., Chung, W., Penninx, B. W., et al. (2016). Integrative approaches for large-scale transcriptome-wide association studies. Nat. Genet. 48, 245-252. doi: 10.1038/ng.3506
27. He, B., Chen, C., Teng, L., and Tan, K. (2014). Global view of enhancer-promoter interactome in human cells. Proc. Natl. Acad. Sci. U.S.A. 111, E2191-E2199. doi: 10.1073/pnas.1320308111
28. Hebbring, S. J. (2014). The challenges, advantages and future of phenome-wide association studies. Immunology 141, 157-165. doi: 10.1111/imm.12195
29. Horton, J. D., Cohen, J. C., and Hobbs, H. H. (2007). Molecular biology of PCSK9: its role in LDL metabolism. Trends Biochem. Sci. 32, 71-77. doi: 10.1016/j.tibs.2006.12.008
30. Hueber, W., Patel, D. D., Dryja, T., Wright, A. M., Koroleva, I., Bruin, G., et al. (2010). Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci. Transl. Med. 2:52ra72. doi: 10.1126/scitranslmed.3001107
31. Johns Hopkins University (2017). OMIM Gene Map Statistics [Online]. Available: http://www.omim.org/statistics/geneMap [accessed June 20, 2017]
32. Joung, J., Konermann, S., Gootenberg, J. S., Abudayyeh, O. O., Platt, R. J., Brigham, M. D., et al. (2017). Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening. Nat. Protoc. 12, 828-863. doi: 10.1038/nprot.2017.016
33. Kaelin, W. G. Jr. (2017). Common pitfalls in preclinical cancer target validation. Nat. Rev. Cancer 17, 425-440. doi: 10.1038/nrc.2017.32
34. Kim, J. H., and Scialli, A. R. (2011). Thalidomide: the tragedy of birth defects and the effective treatment of disease. Toxicol. Sci. 122, 1-6. doi: 10.1093/toxsci/kfr088
35. Koscielny, G., An, P., Carvalho-Silva, D., Cham, J. A., Fumis, L., Gasparyan, R., et al. (2017). Open targets: a platform for therapeutic target identification and validation. Nucleic Acids Res. 45, D985-D994. doi: 10.1093/nar/gkw1055
36. Kremer, S., and Jones, R. (2015). Old Drugs, New Tricks: Patent Considerations in Drug Repurposing [Online]. Available at: http://www.lexology.com/library/detail.aspx?g=0e11981f-5268-4b0f-b6a6-1cb27e97e07c
37. Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., et al. (2006). The connectivity map: using gene-expression signatures to connect small molecules, Genes, and disease. Science 313, 1929-1935. doi: 10.1126/science.1132939
38. Law, V., Knox, C., Djoumbou, Y., Jewison, T., Guo, A. C., Liu, Y., et al. (2014). DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res. 42, D1091-D1097. doi: 10.1093/nar/gkt1068
39. Li, G., Chen, Y., Snyder, M. P., and Zhang, M. Q. (2017). ChIA-PET2: a versatile and flexible pipeline for ChIA-PET data analysis. Nucleic Acids Res. 45:e4. doi: 10.1093/nar/gkw809
40. Li, M. J., Wang, L. Y., Xia, Z., Sham, P. C., and Wang, J. (2013). GWAS3D: detecting human regulatory variants by integrative analysis of genome-wide associations, chromosome interactions and histone modifications. Nucleic Acids Res. 41, W150-W158. doi: 10.1093/nar/gkt456
41. Lu, Y., Quan, C., Chen, H., Bo, X., and Zhang, C. (2017). 3DSNP: a database for linking human noncoding SNPs to their three-dimensional interacting genes. Nucleic Acids Res. 45, D643-D649. doi: 10.1093/nar/gkw1022
42. MacArthur, J., Bowler, E., Cerezo, M., Gil, L., Hall, P., Hastings, E., et al. (2017). The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog). Nucleic Acids Res. 45, D896-D901. doi: 10.1093/nar/gkw1133
43. Manolio, T. A., Collins, F. S., Cox, N. J., Goldstein, D. B., Hindorff, L. A., Hunter, D. J., et al. (2009). Finding the missing heritability of complex diseases. Nature 461, 747-753. doi: 10.1038/nature08494
44. Markham, A. (2015). Evolocumab: first global approval. Drugs 75, 1567-1573. doi: 10.1007/s40265-015-0460-4
45. Michailidou, K., Beesley, J., Lindstrom, S., Canisius, S., Dennis, J., Lush, M. J., et al. (2015). Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nat. Genet. 47, 373-380. doi: 10.1038/ng.3242
46. Mifsud, B., Tavares-Cadete, F., Young, A. N., Sugar, R., Schoenfelder, S., Ferreira, L., et al. (2015). Mapping long-range promoter contacts in human cells with high-resolution capture Hi-C. Nat. Genet. 47, 598-606. doi: 10.1038/ng.3286
47. Moosavinasab, S., Patterson, J., Strouse, R., Rastegar-Mojarad, M., Regan, K., Payne, P. R., et al. (2016). 'RE:fine drugs': an interactive dashboard to access drug repurposing opportunities. Database (Oxford) 2016:baw083. doi: 10.1093/database/baw083
48. National Institutes of Health (2015). Transforming Translational Research. Rockville, MD: National Institutes of Health
49. Nelson, M. R., Tipney, H., Painter, J. L., Shen, J., Nicoletti, P., Shen, Y., et al. (2015). The support of human genetic evidence for approved drug indications. Nat. Genet. 47, 856-860. doi: 10.1038/ng.3314
50. Nosengo, N. (2016). New tricks for old drugs. Nature 534, 314-316
51. Paton, D. M. (2016). PCSK9 inhibitors: monoclonal antibodies for the treatment of hypercholesterolemia. Drugs Today (Barc) 52, 183-192. doi: 10.1358/dot.2016.52.3.2440527
52. Prinz, F., Schlange, T., and Asadullah, K. (2011). Believe it or not: how much can we rely on published data on potential drug targets? Nat. Rev. Drug Discov. 10, 712. doi: 10.1038/nrd3439-c1
53. Ragvin, A., Moro, E., Fredman, D., Navratilova, P., Drivenes, O., Engstrom, P. G., et al. (2010). Long-range gene regulation links genomic type 2 diabetes and obesity risk regions to HHEX, SOX4, and IRX3. Proc. Natl. Acad. Sci. U.S.A. 107, 775-780. doi: 10.1073/pnas.0911591107
54. Ramasamy, A., Trabzuni, D., Guelfi, S., Varghese, V., Smith, C., Walker, R., et al. (2014). Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat. Neurosci. 17, 1418-1428. doi: 10.1038/nn.3801
55. Roadmap Epigenomics Consortium, Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., et al. (2015). Integrative analysis of 111 reference human epigenomes. Nature 518, 317-330. doi: 10.1038/nature14248
56. Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., et al. (2017). Evolocumab and clinical outcomes in patients with cardiovascular disease. N. Engl. J. Med. 376, 1713-1722. doi: 10.1056/NEJMoa1615664
57. Scannell, J. W., Blanckley, A., Boldon, H., and Warrington, B. (2012). Diagnosing the decline in pharmaceutical R&D efficiency. Nat. Rev. Drug Discov. 11, 191-200. doi: 10.1038/nrd3681
58. Schmitt, A. D., Hu, M., and Ren, B. (2016). Genome-wide mapping and analysis of chromosome architecture. Nat. Rev. Mol. Cell Biol. 17, 743-755. doi: 10.1038/nrm.2016.104
59. Schunkert, H., Konig, I. R., Kathiresan, S., Reilly, M. P., Assimes, T. L., Holm, H., et al. (2011). Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat. Genet. 43, 333-338. doi: 10.1038/ng.784
60. Servant, N., Varoquaux, N., Lajoie, B. R., Viara, E., Chen, C.-J., Vert, J.-P., et al. (2015). HiC-Pro: an optimized and flexible pipeline for Hi-C data processing. Genome Biol. 16:259. doi: 10.1186/s13059-015-0831-x
61. Smemo, S., Tena, J. J., Kim, K. H., Gamazon, E. R., Sakabe, N. J., Gomez-Marin, C., et al. (2014). Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature 507, 371-375. doi: 10.1038/nature13138
62. Smietana, K., Siatkowski, M., and Moller, M. (2016). Trends in clinical success rates. Nat. Rev. Drug Discov. 15, 379-380. doi: 10.1038/nrd.2016.85
63. Szklarczyk, D., Morris, J. H., Cook, H., Kuhn, M., Wyder, S., Simonovic, M., et al. (2017). The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible. Nucleic Acids Res. 45, D362-D368. doi: 10.1093/nar/gkw937
64. Teng, L., He, B., Wang, J., and Tan, K. (2015). 4DGenome: a comprehensive database of chromatin interactions. Bioinformatics 31, 2560-2564. doi: 10.1093/bioinformatics/btv158
65. Thompson, D. J., O'Mara, T. A., Glubb, D. M., Painter, J. N., Cheng, T., Folkerd, E., et al. (2016). CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer. Endocr. Relat. Cancer 23, 77-91. doi: 10.1530/ERC-15-0386
66. Tsherniak, A., Vazquez, F., Montgomery, P. G., Weir, B. A., Kryukov, G., Cowley, G. S., et al. (2017). Defining a cancer dependency map. Cell 170, 564-576.e16. doi: 10.1016/j.cell.2017.06.010
67. U.S. Department of Health and Human Services (2017). Drugs@FDA: FDA Approved Drug Products [Online]. Washington, DC: U.S. Department of Health and Human Services
68. Visscher, P. M., Wray, N. R., Zhang, Q., Sklar, P., McCarthy, M. I., Brown, M. A., et al. (2017). 10 years of GWAS discovery: biology, function, and translation. Am. J. Hum. Genet. 101, 5-22. doi: 10.1016/j.ajhg.2017.06.005
69. Wagner, A. H., Coffman, A. C., Ainscough, B. J., Spies, N. C., Skidmore, Z. L., Campbell, K. M., et al. (2016). DGIdb 2.0: mining clinically relevant drug-gene interactions. Nucleic Acids Res. 44, D1036-D1044. doi: 10.1093/nar/gkv1165
70. Westra, H.-J., Peters, M. J., Esko, T., Yaghootkar, H., Schurmann, C., Kettunen, J., et al. (2013). Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat. Genet. 45, 1238-1243. doi: 10.1038/ng.2756
71. Whirl-Carrillo, M., McDonagh, E. M., Hebert, J. M., Gong, L., Sangkuhl, K., Thorn, C. F., et al. (2012). Pharmacogenomics knowledge for personalized medicine. Clin. Pharmacol. Ther. 92, 414-417. doi: 10.1038/clpt.2012.96
72. Xie, X., Ma, W., Songyang, Z., Luo, Z., Huang, J., Dai, Z., et al. (2016). CCSI: a database providing chromatin-chromatin spatial interaction information. Database (Oxford) 2016:bav124. doi: 10.1093/database/bav124
73. Yu, C. H., Pal, L. R., and Moult, J. (2016). Consensus genome-wide expression quantitative trait loci and their relationship with human complex trait disease. OMICS 20, 400-414. doi: 10.1089/omi.2016.0063
74. Zhu, Z., Zhang, F., Hu, H., Bakshi, A., Robinson, M. R., Powell, J. E., et al. (2016). Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 48, 481-487. doi: 10.1038/ng.3538